11 September 2006 Early panretinal photocoagulation for the treatment of ischemic central retinal vein occlusion
Author Affiliations +
Proceedings Volume 5967, 2004 Shanghai International Conference on Laser Medicine and Surgery; 59671M (2006) https://doi.org/10.1117/12.639341
Event: 2004 Shanghai international Conference on Laser Medicine and Surgery, 2004, Shanghai, China
Abstract
Objective: To evaluate the safety and efficacy of treating ischemic central retinal vein occlusion (CRVO) with early panretinal photocoagulation (PRP). Methods: 24 eyes of 24 cases suffered from ischemic CRVO with history shorter than 3 months were included in this study. PRP treatments were completed through 3 to 5 times of laser therapy with total laser burns of 1000 to 2000 (mean 1505±384). Patients were followed up 3 months to 2 years, mean 18.4±8.0 months. The neovascularization regression and visual acuity were compared before and after PRP, also the long-term complications were observed. Results: 3 eyes of iris neovascularization (INV) regressed after PRP and there was no significant difference in visual acuity between prelaser and postlaser. No neovascular glaucoma (NVG) occurred and 2 eyes occurred vitreous hemorrhage during the follow up period. Conclusions: Early panretinal photocoagulation is safe and efficacious in preventing and reducing complications of ischemic CRVO. It can save valuable treatment time for some patients.
© (2006) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Zikui Yu, Zikui Yu, Naizhen He, Naizhen He, } "Early panretinal photocoagulation for the treatment of ischemic central retinal vein occlusion", Proc. SPIE 5967, 2004 Shanghai International Conference on Laser Medicine and Surgery, 59671M (11 September 2006); doi: 10.1117/12.639341; https://doi.org/10.1117/12.639341
PROCEEDINGS
4 PAGES


SHARE
Back to Top